| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.082 | 0.08 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.08 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.073 | 0.08 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.052 | 0.08 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.083 | 0.09 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.09 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.09 |